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ABSTRACT: in response to the increasing need 
for research ethics expertise in low- and middle-
income countries (LMICs), the NIH’s Fogarty 
International Research Ethics Education and Curr-
iculum Development Program has provided grants for 
the development of training programs in international 
research ethics for LMIC professionals since 2000. This 
collection of papers draws upon the combined exper-
tise of Fogarty grantees, trainees, and other experts to 
assess the state of research ethics in LMICs, and the 
lessons learned over 12 years of international research 
ethics education; to assess future needs; and to chart a 
way forward to meet those needs. In this introductory 
paper we briefly sketch the evolution of research ethics 
as applied to LMIC research, the underpinning and 
evolution of the Fogarty bioethics program, and sum-
marize key conclusions from the other papers in the 
collection.
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When health research takes place in low- and middle-income countries (LMICs), in which many potential participants are 
poor, lack access to good quality health care outside of 
research studies, have little political power, and may be 
illiterate and unfamiliar with modern medicine, 
concerns about exploitation and other potential ethical 
violations are heightened. The fact that most of the 
health research conducted in LMICs is sponsored by 
multinational pharmaceutical companies and research 
funding institutions in high-income countries (HICs) 
may further fuel concerns. While this research can be 
extremely important and have beneficial impacts on the 
health of LMIC populations, before it proceeds it 
requires careful scrutiny by people with scientific and 
ethical expertise who understand the cultural and 
socio-economic context in which it will take place. 
In response to the increasing need for research ethics 
expertise in LMICs, the NIH’s Fogarty International 
Research Ethics Education and Curriculum Development 
Program has provided grants for the development of 
training programs in research ethics for LMIC profes-
sionals since 2000 (Fogarty International Center [FIC], 
2012). Grantees, selected after rigorous independent 
peer review, receive support to develop socioculturally 
relevant, graduate-level international research ethics 
curricula for LMIC participants, including foundational 
ethical theory, international guidance, research case 
studies, and relevant practicum experiences. The train-
ing centers invite LMIC researchers, health professionals, 
and academics to apply for a mentored 1–2 year training 
experience and reentry activities at their home institu-
tions, fully supported by the Fogarty grant. This training 
is expected to prepare participants to lead ethical review 
of research in their home setting, to contribute to an 
international discussion of research ethics issues in 
LMICs, to train others in research ethics, and to develop, 
implement, and disseminate research ethics guidance. 
Twelve years after the inception of the program, the 
global health research landscape has evolved. Within 
research ethics, there remains a commitment to core 
principles, but attention has focused more on the 
nuances of how to apply fundamental research ethics 
principles to the increasingly complex realm of health 
research (Table 1). Despite the increase in the number of 
formally educated bioethicists in developing countries, 
the need for ethical expertise in the design, review, and 
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conduct of health research in LMICs has only expanded 
as the amount of research in LMICs has increased. This 
collection of papers draws upon the combined expertise 
of many of the Fogarty grantees, trainees, and other 
affiliated experts to assess the state of research ethics in 
LMICs and the lessons learned over 12 years of interna-
tional research ethics education, to identify future needs, 
and to chart a way forward to help meet those needs.  
This collection includes five regional papers, covering 
Sub-Saharan Africa, Asia, Central and Eastern Europe, 
Latin America, and the Middle East. In addition, topical 
papers address mentoring, scholarly productivity, cur-
riculum analysis, teaching about vulnerability, Asian 
perspectives on ethics, identifying policy gaps in research 
ethics, methods for evaluating ethics education programs, 
and distance learning. In this introductory paper we 
sketch the development of research ethics as applied to 
LMIC research, describe the underpinning and evolution 
of the Fogarty research ethics program, and summarize 
some key conclusions from the collection. 
InternatIonal research ethIcs before 2000
Concerns about the ethics of conducting risky medical 
experiments on humans in an international context 
date back more than a century (Timeline). In 1898, in 
Prussia, Albert Neisser was fined for experimentally 
injecting patients with syphilitic serum without their 
consent (Vollmann & Winau, 1996). Two years later, 
Walter Reed’s well-known yellow fever experiments in 
Cuba included volunteers who signed consent forms 
agreeing to be exposed to transmission of the virus 
from mosquitoes, despite the fact that no treatment was 
available (Lederer, 2008). The President’s Advisory 
Commission on Human Radiation Experiments found 
that “as early as 1944 it was conventional for physicians 
and other biomedical scientists to obtain consent from 
healthy subjects of research.” However, “physicians 
engaged in clinical research [on sick patients] generally 
did not obtain consent from patient-subjects” (Advisory 
Committee on Human Radiation Experiments, 1996, 
Finding 10).  
Much has been written about the medical experiments 
undertaken by Nazi physicians during World War II and 
their trial at the Nuremberg Military Tribunals, where 
they were charged with war crimes and crimes against 
humanity (Weindling, 2008). However, some unethical 
international medical research continued after the war. 
Between 1946 and 1948 U.S. government researchers 
conducted experiments in Guatemala that involved 
deliberately infecting subjects with venereal diseases, 
including syphilis, without their consent. A recent report 
investigating these unethical experiments suggests atti-
tudes that may have been typical of medical researchers 
at the time:
…investigators were operating within a culture of 
medical research that often treated moral norms 
pragmatically, primarily as defenses against med-
dling “do-gooders” who would impinge upon their 
all-important work, rather than genuine moral 
imperatives based on respect for persons. 
(Presidential Commission for the Study of 
Bioethical Issues, 2011, p. 97)   
Concerns about ongoing unethical research were subse-
quently raised by Henry Beecher in the U.S. and 
Maurice Pappworth in the U.K. (Beecher, 1966; 
Pappworth, 1962, 1967). International guidance for con-
ducting research involving human subjects was made 
explicit in the World Medical Association’s Declaration 
of Helsinki in 1964.
The few discussions of the ethics of international 
health research over the next few years were primarily 
among academic researchers in HICs, especially 
regarding “helicopter” medical research, which 
entailed investigators from HIC institutions flying 
into an LMIC, taking patient specimens and data, and 
flying out without providing any benefit to the host 
community. Other commentators worried about “eth-
ical imperialism”—imposing the ethical values and 
practices of the West on communities for whom these 
values were foreign. Some questioned, for example, 
whether the requirement for individual informed 
TABLE 1. evolving  International research ethics landscape.
early concerns transitions beginning late 1990s current
Exploitation, helicopter research Responsiveness and post-trial planning to minimize  
exploitation
Collaborative partnerships, benefit 
sharing, responsiveness
Ethical imperialism Capacity building Partnership, community engagement, 
capacity building
Inappropriateness of Western  
norms such as informed consent
Expanding commitment to individual informed consent, 
respect for permission of community or tribal leaders
Continued commitment to improving 
informed consent everywhere
Standards of care in study design Standards of care, ancillary care, 
post-trial care
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consent was appropriate in cultures who believed in 
the priority of the community or family over the 
individual. Commenting on this dilemma in 1979, 
Carl E. Taylor wrote:
Where most decisions about treatment are 
communal, is it only a facade to insist on individual 
consent? Does it not simplify and make more realistic 
and honest a process whereby community leaders 
give consent since individuals would follow their 
advice in any case? (Taylor, 1979, pp. 982–983)
However, it was the question of the “standard of care” 
offered to research participants in HIV/AIDS trials in 
developing countries that drew global attention to the 
special ethical issues that can arise with research in poor 
communities. Due to the cost of drugs, deficiencies in 
health infrastructure, and lack of routine prenatal care, it 
was impossible to implement the HIC standard of care to 
prevent mother to child HIV transmission in the LMICs 
where HIV was spreading most rapidly (Connor et al., 
1994). Following a WHO meeting to evaluate the research 
agenda, a group of placebo-controlled trials of short-
course zidovudine and other more LMIC-appropriate 
modalities for reducing perinatal HIV transmission were 
implemented in several high-incidence African, Asian, 
and Caribbean countries (Lavery et al., 2007).
In September 1997, Peter Lurie and Sidney Wolfe pub-
lished an opinion piece in the New England Journal of 
Medicine criticizing these trials: “In our view, most of 
these trials are unethical and will lead to hundreds of 
preventable HIV infections in infants” (Lurie & Wolfe, 
1997, p. 853).   
The debate over the placebo-controlled perinatal HIV 
studies of “short-course AZT” polarized ethical discus-
sion. On the one side were those who thought that 
conducting placebo-controlled trials when there existed 
proven effective treatments showed unethical “double 
standards” between rich and poor countries (Angell, 
1997). Others thought that the local context was essential 
to determining whether a clinical trial was ethical 
(Varmus & Satcher, 1997, pp. 1003–1004). Edward 
Mbidde, Chairman of the AIDS Research Committee of 
the Uganda Cancer Institute, wrote: 
Ugandan studies are responsive to the health needs 
and the priorities of the nation. Research subjects 
have been selected in such a way that the burdens 
and benefits of the research will be equitably dis-
tributed, and the appropriate authorities, including 
the national ethics review committee, have satisfied 
themselves that the research meets their own ethi-
cal requirements. With these requirements met, if 
Ugandans cannot carry out research on their people 
for the good of their nation, applying ethical stan-
dards in their local circumstances, then who will? 
(Mbidde, 1998, p. 836)
But among the 13 letters of correspondence from 25 
authors the New England Journal of Medicine pub-
lished in response to the Lurie and Wolff and Angell 
critiques, just four authors were identified as from 
LMIC institutions.  
The Fogarty International Center’s Research  
Ethics Program
Development of the program  
In the wake of the debate over the perinatal HIV trans-
mission trials, it was clear that insufficient attention 
was paid to voices from LMICs on the ethics of clinical 
research that directly affected their populations. In 
November 1999, under Director Gerald Keusch, FIC 
organized the first in a series of meetings of the Global 
Forum on Bioethics in Research (www.gfbronline.
com/), which discussed LMIC clinical trials and the 
need for long-term training in research ethics. Karen 
Hofman, then at FIC, summed up its conclusions:
The participants agreed … that a consortium of 
sponsors is urgently needed to develop a long-term 
training initiative in the bioethics of research, 
which would be offered in various countries. This 
new paradigm of support for international activities 
would have positive trans-cultural implications and 
help establish linkages between research funded by 
various international organizations and capacity 
development in bioethics. (Hofman, 2000, p. 175)
FIC has a long history of supporting collaborative 
research and research training programs between U.S. 
and LMIC institutions, which have been successful at 
building sustainable capacity in scientific research. 
Although some short-term research ethics training had 
been offered in various LMICs at the time of the Forum, 
there was a lack of in-depth internationally focused 
research ethics curricula and faculty with sufficient 
international research ethics expertise. Following the 
Global Forum, FIC settled on two primary goals for 
international research ethics training grant proposals, 
which were encompassed in a request for applications 
issued in 2000:
(1)  Develop socioculturally relevant master’s level 
international research ethics curricula covering 
foundational ethical theory, international 
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research ethics guidance, LMIC research case 
studies, and ethics practicum experiences (e.g., 
research review, pedagogy, consultation, policy, 
and regulation).
(2)  Provide in-depth training in research ethics to 
LMIC researchers, health professionals, and 
academics in positions to have an immediate 
impact at their institutions (e.g., train others in 
research ethics, lead ethics review, develop 
institutional, national, and international ethics 
guidance for research, and contribute to ethical 
debate on LMIC research issues).
Involvement of lmIc InstItutIons anD faculty
In eight calls for proposals since 2000, 36% of 165 
total applications have been submitted from LMIC 
institutions, and 44% of all applications from LMIC 
institutions have been funded (in Argentina, 
Bangladesh, Brazil, Chile, China, India, Nigeria, 
Pakistan, Philippines, Russia, South Africa, and 
Uganda), compared to 39% from U.S. institutions. 
Among the 60 grants funded through 2011, 43% were 
awarded to LMIC institutions, compared to 48% to 
U.S. institutions and 8% to non-U.S. HIC institutions 
(in Canada and Australia).  In order to encourage 
applications from the research ethics community and 
LMIC institutions not familiar with the NIH grants 
process, FIC also provided grants writing workshops 
and offered small two-year planning grants to LMIC 
applicants to plan curricula, strengthen faculty, and 
meet with collaborators. 71% of the initial awards to 
LMIC grantees were for planning grants. Afterwards, 
55% of planning grantees submitted successful full 
training applications. All subsequently competed suc-
cessfully for renewal grants 4 or 5 years later. By 
comparison, only 33% of LMIC applications funded 
for full training programs on their initial proposal 
were able to secure renewal support. 
Although collaboration is not required, HIC applicants 
have always been strongly encouraged to include LMIC 
faculty and advisory committee members. Some LMIC 
trainees with faculty members or co-directors in HIC-
based training institutions have applied successfully for 
a training grant for their home institutions. When NIH 
policy changed in 2006 to allow multiple principal inves-
tigators to be designated on a single application, many 
subsequent HIC applications included LMIC collabora-
tors as principal investigators. Increasing numbers of HIC 
programs conduct the majority of their training activities 
at LMIC partner institutions. 
aDDressIng traInee neeDs 
Since 2000, 20 training programs have graduated 
approximately 600 long-term trainees from 74 LMICs, 
the majority with health professional backgrounds 
(Matar et al., forthcoming). While strengthening of 
RECs has not been a direct goal of the program, it has an 
indirect impact on them by helping to develop human 
capacity in participating LMIC countries. Education on 
REC regulations, operations, and the skills needed for 
effective REC operation are widely included in program 
curricula (Matar et al., forthcoming).  
English is increasingly the unofficial common lan-
guage of science. However, the nuances of language are 
critical to the expression and understanding of ethical 
concepts. HIC institutions offering training to 
participants from non-English speaking countries now 
provide didactic training at collaborating LMIC institu-
tions in local languages, including Spanish, French, 
Urdu, and Chinese.   
People’s understandings of ethics are also a product 
of culture. Pratt et al. in their literature review of per-
spectives from South and East Asia on clinical and 
research ethics examine the English language literature 
of relevance to bioethics in four Asian countries (Pratt 
et al., forthcoming). Their analysis illuminates the rela-
tionship between the foundational ethical and religious 
concepts of these countries and the dominant Anglo-
American views, presents data on how relationships 
between doctors and patients or research participants 
are evolving, and cautions against the mindless imposi-
tion of  “international standards,” which might then be 
adopted in name only. The analysis of program curricula 
suggested that while some program directors thought 
that there were concerns about the influence of Western 
bioethical concepts, others did not, and many had 
incorporated discussions of secular Western and indig-
enous or religious value systems into their curricula 
(Matar et al., forthcoming). Faculty in another training 
program found that new trainees from Russia and 
Romania lacked an understanding of the current, widely 
accepted concept of “vulnerability” and an appreciation 
for the need to protect vulnerable populations in 
research. Loue and Loff (2013a, this issue) consider the 
political and cultural conditions that might have 
fostered this problem and describe educational inter-
ventions developed to address it.
DIstance learnIng
The evolution of electronic communication technolo-
gies during the lifespan of the program offered new 
tools for education. FIC funded the first distance-
learning research ethics training grant from an HIC 
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institution for an LMIC region in 2004. Subsequently, 
additional training sites have incorporated hybrid 
distance-learning approaches into their curricula as 
Internet access, appropriate technology, and adaptable 
electronic training resources have emerged. Silverman 
et al. (2013, this issue) conducted an evaluation of four 
current online courses using a combination of face-
to-face and distance-learning approaches to identify 
areas for quality improvement. The results show that 
the courses meet most of the best practice criteria for 
the field of online courses. They also suggest that con-
tinued sharing of expertise and experiences could sup-
port all the courses to meet best practice criteria where 
deficiencies exist.
scholarshIp
FIC trainees have made important contributions to the 
international bioethics literature, particularly with 
regard to HIV/AIDS and TB research, vaccine research, 
biotechnology research, ethical review committees, 
community engagement, and informed consent. While 
the 20 most-cited trainee publications were primarily 
published in high-impact international journals (6 in 
PloS Medicine, 4 in Social Science and Medicine, 3 in 
Journal of Medical Ethics, and 2 in Nature Biotechnology), 
trainees also contributed to the development or expan-
sion of national or regional  journals (including 
Romanian Journal of Bioethics, Indian Journal of Medical 
Ethics, Acta Bioethica, Revista Romana de Bioetica, and 
African Journal of Medicine and Medical Sciences). 12.6% 
of trainee papers (n=328) published between 2004 and 
2008 were cited more than 10 times (Fix et al., 2013, 
this issue).  
crItIcIsm of the program
Although it has been widely supported, the FIC bioeth-
ics training program has also faced criticisms that it 
attempts to impose U.S. conceptions of research ethics 
on other cultures and serves the goals of the U.S. gov-
ernment and pharmaceutical industry by preparing 
foreign research sites to host their clinical trials. Ruth 
Chadwick and Udo Schüklenk commented in an edito-
rial in Bioethics subtitled “Bioethical Colonialism?”:
International agencies provide significant amounts 
of funding designed to improve research ethics 
capacity in the developing world. The strings 
attached: budding research ethicists in the develop-
ing world have to undergo “training” in institutions 
of the rich north, thereby implying that there is 
insufficient intellectual and personnel capacity 
locally to train ethicists. … [O]ne has reason to  
be sensitive to claims by developing world based 
bioethicists that much of this “training’’ really 
constitutes a form of ideology transfer. …The cur-
rent assumption seems to be that the developing 
world needs our training and needs to be subjected 
to significant doses of our ethical views and ideolo-
gies, instead of funding allowing it to develop its 
own capacities based on its own thinking. 
(Chadwick & Schüklenk, 2004, pp. iii–iv)
Douglas Wassenaar, an FIC training program grantee at 
the University of KwaZulu-Natal in South Africa, com-
mented on this misconception in the context of Africa 
on the Hastings Center Report blog: 
To the best of my knowledge, not one of these pro-
grams … aims to replicate the U.S. IRB system. 
Instead, they aim to enhance the ability of African 
researchers, scientists, research ethics committee 
members and other stakeholders to debate precisely 
the ethical issues … and to generate ethically con-
sidered solutions to local ethical dilemmas, using 
the best international resources applied to deep 
knowledge of local conditions. (Wassenaar, 2006)   
system anD program analysIs
In the U.S., despite the vast amount of time and money 
invested into IRB review, there is agreement on the 
burden that ethics review places on researchers and 
institutions, but no data on whether the system protects 
research participants (Grady, 2010). Strosberg, Gefanas, 
& Famenka (forthcoming) describe an analytical frame-
work designed to identify gaps in the public policies 
establishing research ethics review systems that impede 
them from doing their job of protecting human research 
subjects and show how it can be applied to several ex-
Communist countries. Evaluating individual research 
ethics education programs also poses interesting chal-
lenges with regard to the identification of appropriate 
outcomes and ways to measure them. Ali et al. (forth-
coming) describe a framework and tool that the Johns 
Hopkins University Fogarty African Bioethics Training 
Program developed for evaluating  trainee professional 
accomplishments as well as the individual, institutional, 
and program-specific factors associated with post-
training success in research ethics.
Where Are We Now?
the changIng health research lanDscape
Over the last few years the amount of research con-
ducted in LMICs has continued to increase. Although 
in absolute numbers the top nine trial hosts are all still 
high-income countries, 24 of the fastest-growing 25 
8    J. Millum, C. Grady, G. Keusch, B. Sina
trial site locations are LMICs (Thiers et al., 2008). 
Countries such as India and China still have a low den-
sity of trial sites by population and enormous potential 
for growth. Glickman et al. (2009) examined character-
istics of 300 clinical trials reported in JAMA, Lancet, 
and NEJM in 1995 and 2005. In 1995, 33 countries were 
represented as trial site locations, whereas ten years 
later, it was 70. The proportion of trial sites located in 
Africa, Eastern Europe, and the Middle East increased 
while the proportion in the United States, Western 
Europe, and Asia decreased.
Most of this research is still sponsored by institutions 
based in HICs. Some of the increase is due to substantial 
increases in the funding directed towards global health 
(Bollyky, Cockburn, & Berndt, 2010). However, some of 
the increase is a result of pharmaceutical companies tak-
ing advantage of the low costs of research in LMICs and 
the large numbers of treatment-naïve patients. When 
Glickman and colleagues looked at recruitment for 
industry-sponsored phase 3 clinical trials in 2007 they 
found: 
…among the ongoing phase 3 clinical trials that we 
examined that were sponsored by U.S.-based com-
panies in developing countries, none were trials of 
diseases such as tuberculosis that disproportionate-
ly affect the populations of these countries. In 
contrast, we found a variety of trials in developing 
countries for conditions such as allergic rhinitis and 
overactive bladder. (Glickman et al., 2009, p. 819)
current Debates In InternatIonal research ethIcs
Questions about exploitation, consent, and the inap-
propriate imposition of Western norms and regulatory 
requirements continue to be raised. But over the past 
decade or so, the scope of ethical concerns about health 
research in LMICs has expanded, the discussion has 
become more sophisticated, and contributions from 
LMIC authors on these topics have become more 
numerous.   
Questions about what is owed to participants in 
research studies no longer focus solely on the standard 
of care that should be provided as part of the scientific 
design of a clinical trial. Discussion has expanded to 
include the health care that participants should receive 
that is not part of the scientific design of the study 
(ancillary care) and the care that they should receive 
after trials are completed (post-trial benefits) (Sofaer 
& Strech, 2011; Participants, 2008). The question of 
who should pay for these benefits remains unresolved. 
Literature has also examined the proper role of clini-
cal research within theories of justice drawn from 
political philosophy (Millum & Emanuel, 2012). The 
general agreement that “helicopter” research is ethi-
cally problematic has evolved to a greater focus on 
how research projects should be chosen and designed, 
including the importance of equitable partnerships 
with local scientists, and greater involvement of com-
munities in all stages of the research process. Issues 
related to conflicts of interests have become more 
prominent. Recognition that communities, and even 
countries, could be exploited by research has led to 
discussion of the extent to which they should benefit 
from research, for example, by requiring that health 
research be responsive to the community’s health 
needs or that the benefits of research be shared fairly 
with countries that provide the samples and data on 
which it is based. The increase in the amount of mul-
tinational research noted above, and the recent 
proliferation of biobanks, make these issues particu-
larly pressing. 
Research participants in developed and developing 
countries show variable understanding of key elements 
of informed consent, including the purpose of the 
research and its risks (Mandava et al., 2012). While 
there is wide agreement that all competent adults should 
give informed consent to research participation, the 
current focus is on how to improve the quality of 
informed consent. A variety of interventions, including 
shortened consent forms, talking books, culturally sen-
sitive education, and tests of understanding are being 
evaluated in LMIC settings (Dawson & Kass, 2005; 
Dhai, Etheredge, & Cleaton-Jones, 2010; Fitzgerald 
et al., 2005).
LMIC voices are increasingly contributing to dis-
cussion of research ethics issues. When Borry, 
Schotsmans, and Dierickx (2006) investigated the 
geographical differences in research productivity in 
bioethics by looking at the affiliation of first authors 
of articles in nine leading “international” bioethics 
journals between 1990 and 2003, only three of the 21 
most productive countries were LMICs: China, 
Turkey and South Africa. In the 4029 publications 
examined, Chinese first authors contributed 24, com-
pared to 2390 from the U.S. In 2001, the journal 
Developing World Bioethics was launched, as the first 
international journal with an exclusive focus on issues 
in bioethics in LMICs. Along with PloS Medicine and 
Lancet, Developing World Bioethics was the interna-
tional journal that published the largest number of 
FIC trainee publications between 2004 and 2008 (Fix 
et al., 2103, this issue). Although Fogarty research 
ethics trainees have published widely, these publica-
tions are clearly not sufficient to fill the gap identified 
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by Borry and colleagues. Fogarty trainees published 
only 13 papers in the nine journals Borry and coll- 
eagues studied.
the fogarty research ethIcs program In 2012
In the last decade, the amount of research supported 
by NIH in LMICs increased substantially (Roger 
Glass, personal communication, 2013). In parallel, 
the annual program budget grew from approximately 
$1.5 million to over $4 million, which permitted 
increased training grant budgets and   annual grant 
competitions. Figure 1 shows the regional distribu-
tion of funded Fogarty research ethics training grants 
over time. Sub-Saharan Africa—thought to have the 
least research ethics capacity when the program was 
initiated—represents the focus of the majority of 
applications and has averaged approximately 40% of 
total program funding over its lifespan. Training of 
participants from Latin America, Asia, and to a 
lesser extent, Eastern Europe has been supported 
continuously, but it was not until 2004 that training 
for the Middle East was proposed and funded. Figure 
2 displays the accumulated geographic distribution 
of long-term trainees reported by the training sites. 
After more than a decade, the program has sup-
ported approximately 600 long-term research ethics 
trainees in 74 countries, thereby establishing a foun-
dation of leadership and expertise worldwide. 
Looking Ahead
the global pIcture
Global health research will not thrive without a knowl-
edgeable global discussion of the ethics of the research 
to shape its course. Given the expected further increases 
in the health research hosted by LMICs, more capacity 
will have to be built in order to ensure that human sub-
jects protections are maintained even at present levels. 
Moreover, a number of commentators have noted the 
challenges that still face LMIC researchers and RECs. 
Bollyky et al. argue that one of the bottlenecks still 
impeding bringing new products for neglected diseases 
to patients is the inadequacy of the “research and regu-
latory capacity in many neglected disease-endemic set-
tings” (2010, p. 726). They also note that neglected 
disease trials in disease-endemic countries pose par-
ticularly difficult ethical challenges.
Additional sources of support for research ethics activ-
ities for which LMIC trainees can apply have become 
available during the lifespan of the program. These 
include the Ethics and Society Program of the Wellcome 
Trust, the Ethics and Regulatory Projects of the European 
and Developing Countries Clinical Trials Partnership, 
and the Human Heredity and Health in Africa Ethical, 
Legal, and Societal Issues Research Program (H3Africa 
ELSI). In addition, new tools are now available; for 
example, the Council for Health Research and 
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Development (COHRED) has developed a customizable 
web-based system to manage the process of ethical 
reviews (http://rhinno.net). Other sources of indepen-
dent funding for LMIC research ethics doctoral and 
postdoctoral training—as well as research, health, and 
regulatory infrastructure—are needed in order to con-
struct a viable lifelong career pipeline in the field and 
sustain research ethics capacity. Until sufficient support 
for effective and objective RECs at LMIC research 
institutions is provided by external or national sources 
(for example, indirect costs for research grants involving 
human subjects), the full benefit of ethics training for 
the protection of human subjects in research cannot be 
fully realized. 
Career paths in bioethics for trainees and the sustain-
ability of LMIC training sites remain ongoing concerns. 
Even in HICs, individual career paths in bioethics are 
often developed from a patchwork of short-term 
bioethics positions and funding opportunities.  To 
support the career development of research ethics train-
ees, many of the funded programs provide courses in 
scientific proposal development and manuscript writing, 
and practicum experiences in IRB/REC review and man-
agement. Some also support reentry activities in 
teaching, research, or IRB-related projects at trainees’ 
home institutions, and training directors and faculty 
provide long-term mentorship. 
Mentorship is especially critical for trainees transition-
ing to careers where they are expected to apply new 
expertise as a pioneer in the field in their institutional 
setting. Loue and Loff (2013b, this issue) found that the 
most successful mentorship included orienting mentees 
to new responsibilities, a formalized, structured 
mentoring process, frequent contact with mentors, and 
psychosocial as well as academic support. Mentorship is 
not always included as part of traditional pedagogy, and 
therefore faculty may need training in mentorship pro-
cesses and practices in order to enhance trainee success. 
regIonal commonalItIes anD DIfferences
In order to capture commonalities and regional differ-
ences in research ethics needs around the world, we 
surveyed the authors of the regional papers in this col-
lection. We summarized the recommendations from 
each of the regional papers and sent a list of all recom-
mendations to the lead author, asking him/her to rank 
the recommendations for his/her region according to 
whether it was a high priority, lower priority, not a 
priority, or unknown. Responses were received from 
the lead author or a designee for all five papers. The 
regional paper authors were unanimous in identifying 
the education of more trainees, the sustainability of 
their programs, and the career development of former 
trainees as a high priority (Table 2). Consistent with 
these priorities, it was widely agreed that trainees 
needed training in manuscript and grant writing, and 
post-training continuing education. Respondents also 
agreed on the need to engender enhanced critical 
thinking skills in trainees. Perceptions of the need for 
training in additional skills, such as leadership and 
advocacy, and specific curricula content were more 
varied. Outside of the Middle East, flexibility in the 
level of training (from awareness-building workshops 
up to support of doctoral-level research) was regarded 
FIG. 2.
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Timeline: International research ethics
Walter Reed obtains written informed consent for
healthy volunteers in his yellow fever experiments in 
Cuba
“Regulation on New Therapy and Experimentation”
(Germany)
1900
1931
1932
1936
1944
1946
1947
1948
1949
1962
1964
1966
1972
1979
1991
1993
1994
1996
1997
1999
2000
2001
2003
2005
2007
2013
USPHS Tuskegee Syphilis Study begins
Japan’s Wartime Human Biowarfare
Experimentation Program begins
Manhattan Project
Nuremberg Doctors’ Trial
Nuremberg Code
World Medical Association adopts Declaration of Geneva
AMA issues “Rules for Human Experimentation”
USPHS studies of sexually transmitted diseases in
Guatemala
US FDA requires three phases of human clinical
trials before approving a drug for public use
Maurice Pappworth publishes Human Guinea Pigs:
A Warning in the U.K
Declaration of Helsinki
NIH creates the Office for Protection of Research
Subjects and establishes IRBs
NEJM publishes Henry Beecher’s “Ethics and
Clinical Research”
New York Times published front page story on
USPHS Tuskegee Syphilis Study
US National Research Act - Commission for the 
Protection of Human Subjects of Biomedical and 
Behavioral Research, which wrote the Belmont
Report
CIOMS/WHO International Ethical Guidelines for
Biomedical Research Involving Human Subjects   
UNESCO creates International Bioethics Committee Publication of results of AIDS Clinical Trial 076
Pfizer trial of a new antibiotic on children in Kona,
Nigeria during a meningitis outbreak. The company is
later sued by Nigerian minors and their guardians
Lurie & Wolfe, Angell NEJM editorials
First Global Forum on Bioethics in Research
FIC International Research Ethics training grants initiated
NBAC Report on Clinical Trials in Developing Countries
Creation of EDCTP
UNESCO - Universal Declaration on Bioethics and 
Human Rights
Initiation of Wellcome Trust’s Ethics & Society Program
H3Africa Initiates ELSI grants
FIG. 3.
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as a high priority. Likewise, outside of the Middle 
East, greater coordination and cooperation with other 
training initiatives and programs was seen as a high 
priority. This may reflect the fact that the Middle East 
Research Ethics Training Initiative (MERETI) pro-
gram is the only program in the Middle East and 
strong networks already exist among its trainees. All 
regarded trainee and mentoring networks as high 
priorities. 
The regional papers, our brief survey, and other publicly 
available data suggest that most countries still lack the 
critical mass of trainees required to tackle the research 
ethics training, consultation, regulatory, and ethical review 
needs of their research institutions and governments. For 
example, FIC programs have graduated approximately 100 
long-term Latin American trainees. However, the Pan-
American Health Organization lists over 1000 Latin 
American RECs on Health Research Web (www.
healthresearchweb.org/en/home). At the time of writing, 
4772 clinical studies registered with ClinicalTrials.gov 
were located in South America, with another 1835 in 
Central America and 1812 in Mexico. 
South Africa, India, Nigeria, and Egypt each have 
approximately 50 trainees. While these are populous 
countries with a multitude of research institutions, train-
ing programs in these locations foresee a future point 
where the primary challenge is ensuring sustainability 
and possibly more focused training, such as for REC 
administrators or PhDs who will constitute the next gen-
eration of local bioethics scholars. 
best practices   
The designers of future training programs in research 
ethics should pay particular attention to the following 
conclusions from the collection:
TABLE 2. Key recommendations from regional papers. 
Regions: asia (a), central and eastern europe (e), latin america (l), middle east (m), sub-saharan africa (s). 
recommendation high priority lower priority not a priority Don’t Know
continuation
Resources to educate more trainees still needed A, E, L, M, S
curriculum enhancement
Critical thinking A, L, M, S E
Research methodology L, M E, S
Vulnerability and human rights E S L M
Content that fits context and is culturally relevant A, E, S M L
Flexibility in level (from awareness building work-
shops & dissemination to lay public to PhDs & 
postdocs)
A, E, L, S M
post-program Impact skills and support
Writing, publishing, grant-writing A, E, M, S L
Include former trainees in education A, E, M, S L
Leadership E, M, S L
Policy development E, M, S L
Advocacy E, M, S L
Improved program processes
Goals and measures of success for bioethics 
education
L, S E M
Trainee selection: institutional support, senior 
trainees, include REC administrators
L, M, S E
Focus on institutional capacity building A, E, M, S L
Career development of former trainees A, E, L, M, S
Collect data on regional and country needs A, E, L, M, S
Sustainability of programs A, E, L, M, S
enhanced Interaction among programs
Trainee and mentoring networks A, E, L, M, S
REC networks L, M ES
Share syllabi, education resources, faculty 
exchange
A, E, L, S M
Coordinate with other training initiatives and 
bioethics groups
A, E, L, S M
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(1)  Programs should be flexible so that they can 
respond appropriately to the large differences in 
the existing capacities and needs of different 
regions and countries. Some countries have sub-
stantial in-country expertise and others require 
more external support. Some countries still need 
awareness-building workshops. Others now need 
diversification of training for specific roles, such 
as REC administration, scholarship on research 
ethics, and so on. 
(2)  Some LMIC countries are at a transition point, 
where sustainability requires developing advanced 
career paths in research ethics. Trainees with mas-
ter’s degrees need PhDs, and postdoctoral research 
experience, since PhDs are internationally recog-
nized as being able to offer leadership in their 
field.
(3)  It is vital to consider how training will fit into and 
improve the overall system that governs human 
subjects research in the countries in which train-
ees work.
(4)  Programs benefit enormously through collabora-
tion, which includes collaboration between LMIC 
and HIC faculty and institutions within a grant, 
and collaboration between grantees linked in a 
network. 
(5)  Programs flourish through a process of ongoing 
feedback and revision, including through self-
assessment via an independent advisory group, 
reporting of challenges in annual reports to which 
the program officer and others can respond, open 
grant re-competition based on progress reports, 
and revisions to improve the program every 4–5 
years. None of the Fogarty research ethics pro-
grams has remained the same since initiation.
(6)  Finally, no single optimal educational model or 
program design for LMIC research ethics educa-
tion has emerged, suggesting that different models 
are likely to fit different situations and that there 
are good reasons to keep experimenting.
In addition, individual research ethics educators should 
focus on the following:
(1)  The critical role of mentoring and how this should 
be supported in a particular context.
(2)  Understanding the different cultures and practices 
that may affect trainee understanding, learning 
styles, and how researchers and participants con-
duct themselves. They are likely to be variable, 
even within countries, and changing over time.
(3)  The environments in which trainees will work 
make a huge difference to what they need to suc-
ceed (contrast the differing experiences of trainees 
returning to former Soviet countries). 
research agenda
Many of the papers in this collection attempt systematic 
evaluations of the success of different aspects of research 
ethics education, for example, applying a framework for 
evaluating ethics review systems, conducting a quanti-
tative analysis of publications, or synthesizing mentoring 
experiences. Frequently, these are the first attempts to 
conduct these types of evaluations in the context of 
long-term international research ethics training. 
Moving forward, further development and application 
of these methods would help the task of finding ways to 
measure, and thereby improve, the effectiveness of 
research ethics education. The multiple programs 
around the world also present an opportunity to com-
pare how sustainable programs and career paths are 
built in a new field. Finally, the effects of systems of 
ethical review are notoriously difficult to assess. Work 
remains to be done to determine the long-term 
impact—on health research and the rights and welfare 
of research participants—of the global spread of bioeth-
ics expertise over the last decade.
this collection
This collection of papers grew out of discussions regarding 
the best approaches to evaluating the impact of this non-
traditional training program at annual grantee meetings. 
Participants thought that a collaborative grantee and pro-
gram staff self-assessment of the program would capture 
the benefits of the deep knowledge in international 
research ethics education gained through more than a 
decade of experience. Publishing the results of the assess-
ment in a peer-reviewed journal would satisfy the need for 
independent, objective evaluation. It was also thought that 
such a process would answer the most relevant questions 
regarding achievements and gaps, identify best practices, 
and give direction to those who could readily incorporate 
these results into their training programs. The grantees 
identified cross-cutting paper topics and volunteered to 
collaborate on writing one or more articles. Grantees who 
wished to conduct collaborative research for a paper could 
apply for competitively selected supplemental funds. 
Collaborative writing groups with a lead author presented 
plans and drafted initial manuscripts at a four-day writing 
retreat, which were subsequently finalized and shared 
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electronically with all participants for comment. Revised 
manuscripts were edited by the FIC bioethicist and pro-
gram official in collaboration with the lead authors before 
submission for publication.
The collection of papers represents the emergence of a 
community of practice for international research ethics edu-
cation. It has two main purposes. First, it attempts to provide, 
in historical and social context, a picture of the current state 
of international research ethics education and research ethics 
capacity. Though this picture is formed through the 
experiences of the Fogarty research ethics grantees, it is not 
just a description of what they have achieved, but also their 
understanding of the research ethics landscape more broadly. 
Second, the collection presents some of the key lessons about 
research ethics education that the Fogarty grantees have 
learned. These include lessons about how to develop training 
curricula, how to teach research ethics, how to measure and 
present the impact of research ethics education, and teaching 
in different socioeconomic and cultural contexts.
Disclaimer: The views expressed are the authors' own. 
They do not represent the position or policy of the 
National Institutes of Health, U.S. Public Health Service, 
or the Department of Health and Human Services.
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